Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Antidepressants will cheer you up and stop a repeat heart attack

According to the National Institute of Mental Health, depression and heart disease have long been associated, and one can often lead to the other.

6 Jul 2005

Drug therapy may be effective in treating both the manic and depressive phases of bipolar disorder

The condition (bipolar I and II) affects approximately 8 million Americans, who have relied on a combination of drugs to manage their symptoms, and who remain at high risk of committing suicide because of the difficulty in treating the disorder.

6 Jul 2005

Memory aids help people with schizophrenia remember things just as well as healthy people

When encouraged to use memorization strategies commonly employed by healthy individuals, people with schizophrenia can be helped to remember information just as well as their healthy counterparts, a process that in itself seems to spur a normalization of memory-related activities in the brains of people with schizophrenia, suggests new research from Washington University in St. Louis.

6 Jul 2005

Antipsychotic drug risperidone effective in treating autistic children

In a study sponsored by the U.S. National Institute of Mental Health, and conducted over a number of sites, it has been found that the antipsychotic drug risperidone is a safe, effective treatment for children with autism who display tantrums, aggression and often self-injure.

4 Jul 2005

Experts gather in the fields of childhood and adolescent mental-health problems

Renowned experts in the fields of childhood and adolescent mental-health problems will gather in July to discuss new and effective treatments for a wide-range of mental illnesses affecting children and teens.

30 Jun 2005

Bipolar survey indicates how patient satisfaction is achieved

Preliminary results from a large-scale global study of people living with bipolar disorder, presented today at the World Congress of Biological Psychiatry (WCBP), found that patient satisfaction with treatment is achieved through combining broad-based efficacy with a favourable tolerability profile.

30 Jun 2005

Results of global bipolar disorder consumer survey

The World Federation for Mental Health (WFMH) today announced results of a global bipolar disorder consumer survey, Thinking Ahead, at the World Congress of Biological Psychiatry.

29 Jun 2005

Sleep helps memory

A good night's sleep triggers changes in the brain that help to improve memory, according to a new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).

28 Jun 2005

Mental health declining in American teenagers

Adolescents in the United States are more likely to suffer from a mental health disorder than ever before, but getting these teens diagnosed and cared for is a challenge that is not being met, a new book warns.

28 Jun 2005

Foxp2 gene plays an essential role in the development of social communication

The association between Foxp2 and language was first identified in a family in which half the members had severe speech and grammar impairments. Studies showed that all the affected family members had a mutation in the Foxp2 gene.

21 Jun 2005

Brain differences in bipolar disorder shown in MRI

Experts in the U.S., in an attempt to define the abnormalities in the brains of people with bipolar disorder, have used used functional MRI to measure levels of metabolic activity in different areas of the brain.

21 Jun 2005

Novels are the best medicine for psychiatrists

Psychiatrists could improve their clinical skills by putting their feet up with a good novel, rather than burying their noses in academic journals, delegates at the annual conference of The Royal College of Psychiatrists were told today.

21 Jun 2005

'Bed blocking' in one adolescent unit costs NHS over a million

An 18-month study of 'bed blocking' in an adolescent unit in Birmingham has found that the cost to the NHS was over £1 million.

21 Jun 2005

Computer program that enhances the diagnostic accuracy of positron emission tomography (PET)

German scientists developed a computer program that enhances the diagnostic accuracy of positron emission tomography (PET) scans with Alzheimer's patients, opening the door for earlier treatment of this progressive brain disorder. Details of their findings were provided at the Society of Nuclear Medicine's 52nd Annual Meeting in Toronto.

20 Jun 2005

Research suggests that children with a neuropsychiatric disease may be at risk for type 2 diabetes, and vice versa

As many as one in five children with newly diagnosed type 2 diabetes may also have a neuropsychiatric disorder, according to a new study. The illnesses include depression, attention-deficit hyperactivity disorder, autism, developmental delay, schizophrenia, and bipolar disorder.

20 Jun 2005

Bipolar disorder more prevalent and costly than believed

The incidence of bipolar disorder in the general population is considerably higher than earlier studies have indicated, resulting in significantly less productivity and more days lost from work compared to the better known major depressive disorder, according to preliminary findings from a national survey presented today at the Sixth International Conference on Bipolar Disorder.

19 Jun 2005

First demonstration that reduced metabolic activity in the hippocampus may be used to help predict future Alzheimer's disease

New York University School of Medicine researchers have developed a brain scan-based computer program that quickly and accurately measures metabolic activity in a key region of the brain affected in the early stages of Alzheimer's disease.

19 Jun 2005

Specific genetic linkages to bipolar disorder

Despite an intensive effort, researchers have yet to identify the genes that cause bipolar disorder, yet the practical benefits of such a discovery could reap rich rewards for those suffering from the mental illness.

16 Jun 2005

Chronic insomnia medicines have not yet been rigorously evaluated for long-term use

Many of the medications widely used to manage chronic insomnia have not yet been rigorously evaluated for long-term use, according to an independent scientific panel convened this week by the National Institutes of Health.

16 Jun 2005

The most frequently used drugs for treating chronic insomnia have never been approved for that purpose

Vaughn McCall, M.D., M.S., professor and chairman of the Department of Psychiatry and Behavioral Medicine, told a special consensus panel at the National Institutes of Health (NIH) that he could find no evidence that randomized controlled clinical trials had ever been conducted for five of the 10 pharmaceuticals prescribed most often for chronic insomnia.

14 Jun 2005